Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research
Andrew Jiang, Renée R. Handley, Klaus Lehnert, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 13021-13021
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The Formation and Function of the VTA Dopamine System
Guoqiang Hou, Hao Mei, Jiawen Duan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3875-3875
Open Access | Times Cited: 16
The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions
Irina Kerkis, Álvaro Rossan de Brandão Prieto da Silva, Rodrigo Pinheiro Araldi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Polyglutamine disorders: Pathogenesis and potential drug interventions
Shweta Tandon, Prerna Aggarwal, Surajit Sarkar
Life Sciences (2024) Vol. 344, pp. 122562-122562
Closed Access | Times Cited: 8
mTOR inhibition in Q175 Huntington’s disease model mice facilitates neuronal autophagy and mutant huntingtin clearance
Philip Stavrides, Chris N. Goulbourne, James Peddy, et al.
(2025)
Open Access | Times Cited: 1
Genetics and precision genomics approaches to pulmonary hypertension
Eric D. Austin, Micheala A. Aldred, Mona Alotaibi, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401370-2401370
Open Access | Times Cited: 6
The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders
Anna Stasiłowicz-Krzemień, Wiktoria Nogalska, Zofia Maszewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5749-5749
Open Access | Times Cited: 5
Computational Assessment of the Phytochemicals of Panax ginseng C.A. Meyer Against Dopamine Receptor D1 for Early Huntington’s Disease Prophylactics
Jhashanath Adhikari Subin, Ram Lal Shrestha
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3413-3423
Closed Access | Times Cited: 5
One BAG doesn’t fit all: the differences and similarities of BAG family members in mediating CNS homeostasis
Heng Lin, S.V. Ramanan, S.J. Kaplan, et al.
Biological Psychiatry (2025)
Closed Access
mTOR inhibition in Q175 Huntington’s disease model mice facilitates neuronal autophagy and mutant huntingtin clearance
Philip Stavrides, Chris N. Goulbourne, James Peddy, et al.
(2025)
Open Access
Redefining the Pathogenic CAG Repeat Units Threshold in CACNA1A for Spinocerebellar Ataxia Type 6
Yuya Hatano, Tomohiko Ishihara, Sachiko Hirokawa, et al.
Neurology Genetics (2025) Vol. 11, Iss. 2
Closed Access
Genetic therapies for movement disorders - current status
Jacopo Sartorelli, Joanne Ng, Rahimin Affandi Abdul Rahim, et al.
Journal of Neurology (2025) Vol. 272, Iss. 3
Open Access
Exploring the Potential of tsRNA as Biomarkers for Diagnosis and Treatment of Neurogenetic Disorders
Shiqi Zhao, Yujia Wang, Liqun Zhou, et al.
Molecular Neurobiology (2025)
Closed Access
Unveiling the role of Na⁺/K⁺-ATPase pump: neurodegenerative mechanisms and therapeutic horizons
Ramandeep Kaur Sidhu, Kousik Maparu, Shamsher Singh, et al.
Pharmacological Reports (2025)
Closed Access
Solanesol: a promising natural product
Yinchao Ma, Wei Ge, Zheng Dong, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities
Angie K. Torres, Rodrigo G. Mira, Cristina Pinto, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Unraveling Molecular Targets for Neurodegenerative Diseases Through Caenorhabditis elegans Models
Rong-Mei Xu, Qiaoju Kang, Xuefei Yang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3030-3030
Open Access
Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review
Neserin Ali, Usman Sayeed, Syed Monowar Alam Shahid, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Space exploration and risk of Parkinson’s disease: a perspective review
Nilufar Ali, Afshin Beheshti, Greg Hampikian
npj Microgravity (2025) Vol. 11, Iss. 1
Open Access
Protein palmitoylation: biological functions, disease, and therapeutic targets
Yue-Wei Qian, Y Zhao, Feng Zhang
MedComm (2025) Vol. 6, Iss. 3
Open Access
Repurposing Oseltamivir Against CAG Repeat Mediated Toxicity in Huntington’s Disease and Spinocerebellar Ataxia Using Cellular and Drosophila Model
K. P. Singh, Kanav Gupta, Sakshi Shukla, et al.
ACS Omega (2025)
Open Access
Natural products in neurodegenerative diseases: recent advances and future outlook
Lutfun Nahar, Rawiwan Charoensup, Kulyash Kalieva, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Dual inhibition of canonical and noncanonical PAR‐1 by SCH79797 mitigates neurodegeneration in 3‐NP‐induced Huntington's disease: An in vivo and in silico approach
Raghda T. Abdel‐Latif, Hanan S. El‐Abhar, Dalaal M. Abdallah, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access
Dopaminergic system and neurons: role in multiple neurological diseases
Heng Chen, Jieshu Li, Zhixing Huang, et al.
Neuropharmacology (2024) Vol. 260, pp. 110133-110133
Closed Access | Times Cited: 3
Luteolin as potential treatment for Huntington's disease: Insights from a transgenic mouse model
Abuelnor Mohammed, Azza Ramadan, Asim Ahmed Elnour, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 9
Open Access | Times Cited: 3
Single nuclei RNA-seq reveals a medium spiny neuron glutamate excitotoxicity signature prior to the onset of neuronal death in an ovine Huntington’s disease model
Andrew Jiang, Linya You, Renée R. Handley, et al.
Human Molecular Genetics (2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top